Skip to content
The Journal

Recovery, honestly/Compounds

BPC-157 Is Finally Getting a Real Hamstring Test

A pulled hamstring is the gym injury that keeps coming back. The boring fixes have real trials behind them, and the internet's favorite recovery peptide just got its first real human test.

Human clinical trialEarly lab / animal researchEarly human researchRegulatory context3 min

Inspired Labs Editorial/Oct 23, 2026/7 sources

BPC-157 Is Finally Getting a Real Hamstring Test

You're sprinting for a ball, a bus, or your pride. Something grabs the back of your thigh. Now you're limping, googling, and wondering how long this is going to take.

Hamstring strains are the classic gym-and-field injury, and they love to come back. So let's start with what the research says actually helps, then get to the peptide everyone keeps asking about.

What actually gets you back faster?

Moving sooner, it turns out. In a Danish trial, 50 amateur athletes with bad thigh or calf strains started a structured rehab plan either two days after the injury or nine.

The early group was back to sport about three weeks sooner. Same exercises, just started earlier. Couch rest, it turns out, is not a recovery strategy.

A few habits with that kind of backing:

Start gentle loading early, with a pro setting the plan. That Danish group began with easy stretching and light holds, then built up. A physio or sports-medicine clinician decides what "early" means for your leg.

Favor lengthening exercises in rehab. In a Swedish trial of 75 elite soccer players, a rehab plan built around lengthening the hamstring under load got players back in about 28 days, versus about 51 on a conventional plan.

Add Nordic curls before you ever get hurt. You kneel, someone holds your ankles, and you lower yourself toward the floor as slowly as you can. Pooling 15 studies of about 8,500 athletes, programs that included them roughly halved hamstring injuries.

Honest limit: the Swedish and Danish trials were small, and the Nordic curl studies were mostly in team sports. Still, "load it smart" keeps winning.

So where does BPC-157 come in?

If you've spent five minutes in a gym group chat, you've heard BPC-157 called a healing peptide. It's a 15-amino-acid fragment that Croatian researchers first described in the 1990s, based on a protein found in stomach juice.

Since then it has played a very long scrimmage. Hundreds of animal studies report faster tendon, muscle and ligament healing in rats. That's a real body of work, and it's why people are curious.

But rats aren't you, and a scrimmage isn't a game.

What has it done in actual humans?

Not much that you can trust yet. A systematic review published this month searched every major database through June 2026. It found three human studies, about 30 people total: a knee-pain chart review, a small bladder study, and a two-person safety check.

Most people reported feeling better. But none of the studies had a comparison group, so nobody can say whether the peptide did that, or time, or rehab, or hope. The reviewers rated the certainty "very low" and said BPC-157 shouldn't be used outside proper trials.

Literature, not lore.

Wait, there's a real trial now?

Yes, and it's about hamstrings. A small biotech called Hudson Biotech registered a trial this February. It plans to enroll 120 adults with an MRI-confirmed hamstring strain at one hospital in Shenzhen, China.

Half get BPC-157, half get a lookalike placebo, and everyone does the same rehab. Nobody, not the athletes, not the doctors, not the people reading the MRIs, knows who got what. They'll measure how fast people return to sport and how much the injury shrinks on a scan.

Thirty years of scrimmages against rats. February 2027 is the first real game.

That's the earliest the main results are expected. Nothing has been posted yet, and one trial at one site won't settle it either way.

Isn't the FDA about to allow it?

Not yet. In July, an FDA advisory panel narrowly voted to recommend letting pharmacies compound BPC-157, even though FDA's own reviewers recommended against it. The vote isn't binding. As of mid-October, the government had reportedly sent a plan to the White House but hadn't published a rule. We covered that in A Stopgap Is Not an Approval.

If you remember one thing…

For a pulled hamstring, the stuff with receipts is boring: start rehab early, lengthen under load, and do your Nordic curls. BPC-157 is finally walking onto a real field, and the scoreboard won't light up until 2027.

Everything Inspired Labs carries is for Research Use Only. It's lab material, not for your body, and nothing here is medical advice.

Sources

  1. 01Early versus delayed rehabilitation after acute muscle injury — Bayer ML, Magnusson SP, Kjaer M; Tendon Research Group Bispebjerg (2017). N Engl J Med.

    Human-rct (50 amateur athletes, severe thigh or calf strains; rehab started day 2 vs day 9; median return to sport 62.5 vs 83.0 days; one reinjury in the early group). Full trial: Bayer ML et al. Scand J Med Sci Sports. 2018;28(12):2579–2591. https://pubmed.ncbi.nlm.nih.gov/30043997/

  2. 02Acute hamstring injuries in Swedish elite football: a prospective randomised controlled clinical trial comparing two rehabilitation protocols — Askling CM, Tengvar M, Thorstensson A (2013). Br J Sports Med.

    Human-rct (75 players, MRI-verified; lengthening L-protocol mean 28 days vs conventional 51 days to return).

  3. 03Including the Nordic hamstring exercise in injury prevention programmes halves the rate of hamstring injuries: a systematic review and meta-analysis of 8459 athletes — van Dyk N, Behan FP, Whiteley R (2019). Br J Sports Med.

    Human-rct pooled with other designs (15 studies; risk ratio 0.49 overall, 0.52 in the 8 RCTs).

  4. 04Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety — Poolton JT, Minett J, Kazmi A, et al (2026). Acta Orthop Belg.

    Human-open (3 studies, n=30: retrospective knee-pain study n=16, intravesical pilot n=12, IV safety pilot n=2; all uncontrolled; GRADE certainty very low).

  5. 05BPC 157 for Acute Hamstring Muscle Strain Repair (BPC-HAMSTR) — ClinicalTrials.gov (2026). ClinicalTrials.gov (NCT07437547).

    Registry (phase 2, randomized, quadruple-blind, placebo-controlled; estimated 120 participants; start Feb 2, 2026; recruiting; estimated primary completion Feb 14, 2027; one site, Peking University Shenzhen Hospital; record last updated Feb 27, 2026; no results posted).

  6. 06Pharmacy Compounding Advisory Committee meeting, July 23–24, 2026: briefing/points to consider — U.S. FDA (2026). U.S. FDA.

    Regulatory (FDA proposed that BPC-157 free base and acetate NOT be included on the 503A Bulks List).

  7. 07Trump administration advances plan for peptide drugs favored by RFK Jr — Perrone M (2026). Associated Press.

    Regulatory news (White House filing for a plan to let pharmacies temporarily compound some peptides; specifics not public).

Educational material for laboratory research context only. Nothing here is medical advice, a protocol for human use, or a claim that Inspired Labs products diagnose, treat, cure, or prevent disease.

Inspired Labs — Precision. Purity. Performance.